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Abstract:  Owing  to  lack  of  appropriate  model  systems,  investigations  of  meningioma 
biology  have  come  to  a  stop.  In  this  study,  we  developed  a  comprehensive  digestion 
method and defined a culture system. Using this method and system, primary meningioma 
cells in conditioned suspension medium and a hypoxic environment could be amplified in 
spheres and were passaged for more than ten generations. Meningioma sphere cells were 
positive  for  meningioma  cell  markers  and  negative  for  markers  of  neural  cell  types. 
Importantly, we found the cells expressed the stem cell marker, CD133, but not nestin. All 
of the tumor sphere cell populations showed a slower degree of cell proliferation than that 
of human glioma cells and fetal neural stem cells (NSCs). Further studies showed that the 
proliferative rate was positively correlated with CD133 expression. The higher the CD133 
expression, the faster the cell proliferation. With the increase in cell generations, the cell 
proliferation rate gradually slowed down, and CD133 expression also decreased. Single 
CD133
+  cells  rather  than  CD133
−  cells  could  form  spheres.  Thus,  the  results  above 
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indicated that those cells expressing CD133 in spheres might be stem-like cells, which may 
be  responsible  for  efficient  amplification  of  human  meningioma  cells.  Decreased 
expression of CD133 may lead to the failure of long-term passaging. 
Keywords: meningioma cells; CD133; sphere; proliferation 
 
1. Introduction 
Meningioma cell in vitro culture is the foundation of meningioma pathogenesis and drug treatment 
research  [1].  So  far,  a  stable  and  efficient  method  for  meningioma  cell  cultures  has  not  been 
established [2–5]. As we know, pre-clinical studies of meningioma depends on the in vitro and in vivo 
tumor model, in vivo models are also dependent on efficient cell models in vitro. However, primary 
and subcultured human meningioma cells are difficult, compared with other tumor cells. Therefore, 
establishing an efficient meningioma cell model in vitro becomes a necessary means for investigating 
the  molecular  basis  of  their  growth  and  development,  and  subsequently  studying  meningioma 
pathogenesis  and  drug  treatment.  But  the  long-term  subculture  is  difficult,  a  lot  of  meningioma 
research has been conducted mostly in primary cell-based cultures [6–8]. Although several strains have 
been established, except for malignant ones, most of the cell lines achieve immortalization under gene 
intervention, which is bound to change the characteristics of the original tumor cells [9]. Therefore, the 
establishment of efficient meningioma cells in primary culture and subculture systems is important for 
the study of the biology and development of new drug treatments. 
However, it is difficult to obtain a large number of primary meningioma cells and subculture cells, 
due  to  the  following  factors:  (1)  Meningioma  tissue  contains  a  high  percentage  of  interstitial 
matrix/fiber, and it is difficult to digest meningiomas using a single enzyme or mechanical methods. 
And long enzymatic digestion or rigid mechanical separation result in cell disruption and fewer living 
cells. (2) Since the majority of meningiomas are benign, cells grow slowly surrounding the tissue and 
cannot spread far away into the tissue. (3) A system for the cultivation of meningioma cells has not 
been established,  and  it is  not  clear  what  kind of growth factors or hormones could  promote the 
proliferation of meningioma cells. 
In a previous study, our lab established a comprehensive digestion method, which consisted of a 
collagenase/dispase/DNase cocktail combined with four-step digestion. Hueng et al. have demonstrated 
the  existence  of  human  meningioma  cells  showing  stem-like  features  of  sphere-forming  ability, 
self-renewal,  and  CD133  marker  [10].  And  it has  been  demonstrated  that  hypoxia  could  enhance   
the  generation  of  embryonic  stem  cells  and  induced  pluripotent  stem  cells  [11].  In  addition, 
progesterone and androgen receptor-positive rates in meningioma tissues are about 60~90% and 65%, 
respectively [12,13]. A defined medium conditioned by a cell culture might contain some unknown 
factors, perhaps capable of stimulating its own proliferation [14–16]. To overcome those difficulties of 
meningioma  cell  culture  mentioned  above,  in  this  study,  we  applied  the  comprehensive  digestion 
method to digest meningioma tissues, then culture primary cells in the defined stem cell medium and 
hypoxia  system.  A  large  number  of  primary  meningioma  cells  were  obtained  from  six  human 
meningioma tissues digested with our comprehensive digestion method. We found that these primary Int. J. Mol. Sci. 2012, 13  6426 
 
 
meningioma  cells  could  proliferate  and  subculture  over  ten  passages  under  sphere  status  in  a 
conditioned medium and hypoxia system. Cells in sphere expressed not only epithelial membrane 
antigen and vimentin markers, but also CD133. Importantly, we found that the CD133 expression level 
was related with the cell proliferation rate. Our results suggest that stable and efficient culture systems 
for meningioma cells can be established under certain conditions. 
2. Results 
2.1. Spheres Culture of Meningioma Cells from Meningioma Tissues 
Since meningiomas are difficult to digest, a suitable method was designed for digesting meningiomas. 
We used three enzyme cocktail recipes to digest meningiomas, combined with mechanical methods. In 
addition, during the digestive process, a four-step method was used to prevent cell damage caused by 
prolonged digestion. By using these methods, the meningioma tissue could be acutely dissociated into 
individual living cells. 
Subsequently, cells were seeded at a concentration of 5 ×  10
5/mL. The basic culture medium was a 
neural  stem  cell  medium  established  previously  for  culturing  neurospheres.  We  added  20  nM 
progesterone, 100 mM androstenedione in a basic culture medium, because most kinds of meningioma 
express receptors for progesterone and androstenedione. Cells were cultured in a 3% O2, 5% CO2 
atmosphere. The next day, cells began to  gather into small spheres.  Half of the old medium  was 
replaced  with  fresh  medium  every  3  days.  We  named  this  medium  a conditional  medium,  which 
consisted  of  half  of  the  old  culture  medium  and  half  of  the  fresh  medium.  Under  the  conditions 
described  above,  we  established  primary  cultures  from  three  meningioma  subtypes  (Table  1, 
Figure 1A,D,G). 
Figure 1. Morphologies of cells from three subtypes of meningiomas. (A–C) Cells from 
fiber  meningiomas  (A:  primary  spheres  200× ,  B:  the  third  spheres  200× ,  C:  adherent 
sphere 100× ); (D–F) Cells from hemangiopericytoma meningiomas (D: primary spheres 
200× ,  E:  the  third  spheres  200× ,  F:  adherent  sphere  100× );  (G–I)  Cells  from  epithelial 
meningiomas (G: primary spheres 200× , H: the third spheres 200× , I: adherent sphere 100× ). 
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Figure 1. Cont. 
 
Table 1. Summary of patient population. 
Patient #  Sex  Age (yrs)  Pathological Subtype  Passages 
1  M  69  Fiber    10 
2  F  38  Fiber  10 
3  M  52  Recurrence epithelial  15 
4  F  44  Epithelial  15 
5  M  45  Hemangiopericytoma  12 
6  F  40  Hemangiopericytoma  10 
To  determine  whether  primary  spheres  possessed  the  ability  of  self-renewal  and  proliferation, 
primary spheres were gently dissociated into single cells and maintained in the conditional medium. 
We  found  that  these  single  cells  produced  secondary  sphere  formation  after  another  7–9  days, 
indicating that meningioma cells in spheres were capable of self-renewal and proliferation. Then, we 
continued  to  passage  secondary  spheres  to  determine  whether  they  could  form  tertiary  spheres, 
quaternary  spheres  and  so  on.  We  found  that  these  sphere  could  be  passaged  for  more  than   
10 generations (Table 1, Figure 1B,E,H). Among them, cells from two patients could be passaged for 
more than 15 generations. During the culture, we also found that all six samples were easy to adhere 
(Figure 1C,F,I). 
2.2. Monolayer Culture of Meningioma Cells from Spheres 
After primary meningioma cells were obtained ,sphere cells were dissociated into single cells and 
plated in T-25 flasks according to 1:3 or 1:2 split ratios in order to observe whether meningioma cells 
could be cultured and passaged adherently. We found that single cells with a 1:2 split ratio became 
confluent within 6–7 days and could be passaged for 5–6 generations. On the contrary, single cells Int. J. Mol. Sci. 2012, 13  6428 
 
 
with a 1:3 split ratio were not easily confluent. Interestingly, we found that monolayer cells in an 
adherent culture could form a vascular net (Figure 2). 
Figure 2. Single cells under adherent culture form vascular net-like structure (100× ). 
 
2.3. Characterization of Meningioma Cells 
We first investigated whether meningioma cells expressed stem cell markers. Meningioma cells 
exhibited immunoreactivity for CD133 (Figure 3), and a lack of immunoreactivity for nestin (data not 
shown). FACS Analysis also showed there were CD133-positive cells in each subtype of meningioma 
cells (Figure 4). Interestingly, the percentage of CD133-positive cells in epithelial meningiomas was 
higher  compared  with  that  of  fiber  and  hemangiopericytoma  meningiomas  (Figure  4).  And  the 
percentage of CD133-positive cells in two fiber meningiomas was the lowest among six samples,   
i.e. 8.8% and 6.5%, respectively. 
Figure 3. Expression of CD133 of meningioma cells. (A) CD133; (B) Hochest33342; and 
(C) merged. Scale bar = 50 μm. 
 
Meningioma cells of all subtypes of tumors were positive for human epithelial membrane antigen 
(EMA) (Figure 5A–C) and vimentin (Figure 5D–F) staining and desmoplakin (Figure 5G–I) staining, 
and negative for markers of neural cell types such as GFAP for astrocytes and β-tubulin III for neurons 
(data not showed). Since monolayer cells in an adherent culture could form vascular net, we also Int. J. Mol. Sci. 2012, 13  6429 
 
 
detected VEGF expression in double-labeling detection. A small fraction of cells in the detected cells 
were positive for VEGF (Figure 5J–L). Western blot analysis showed that meningioma cells of all 
subtypes expressed EMA, vimentin, and VEGF proteins (Figure 6). 
Figure  4.  Percentage  of  CD133-positive  cells  at  the  third  generation  from  different 
subtypes  of  meningioma  cells.  (A–C)  Meningioma  cells  from  fiber  meningiomas 
(A: control,  B:  1#  patient,  C:  2#  paitent);  (D–F)  Meningioma  cells  from  epithelial 
meningiomas  (D:  control,  E:  5#  patient,  F:  6# paitent);  (G–I)  Meningioma  cells  from 
Hemangiopericytomas (G: control, H: 3# patient, I: 4# patient). 
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Figure 5. Characterization of meningioma cells. (A–C) EMA (A: EMA, B: hochest33342,   
C: merged, Scale bar = 50 μm); (D–F) vimentin (D: vimentin, E: hochest33342, F: merged); 
(G–I) Desmoplakin (G: Desmoplakin, H: hochest33342, I: merged). Scale bar = 10 μm. 
(J–L)  double-labeling  VEGF  and  vimentin  (J:  vimentin,  K:  VEGF,  L:  merged),   
Scale bar = 10 μm. 
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Figure 6. Protein expression analyzed by Western blotting. 1, 2, 3, 4, 5, 6 is the No. of the 
patient. Western blotting showed that each subtype of meningioma cells expressed vimentin, 
EMG and VEGF. 
 
2.4. Cell Proliferation Features 
To evaluate the proliferative capacity of the tumor cells, we compared cell proliferation features of 
different subtypes of tissue-derived cells, the same tissue-derived cells in different culture status, and 
the same tissue-derived cells in different generations. Cells were plated at 1000 cells/well, and the 
number of viable cells was quantified on days 0, 1, 3, 5, and 7 after plating. For different subtypes of 
tissue-derived  cells,  all  of  the  tumor  sphere  cell  populations  assayed  demonstrated  increased 
proliferative capacity, but showed a slower degree of cell proliferation than that of human glioma and 
fetal NSCs (Figure 7A). For the same tissue-derived cells in different culture status, cells in spheres 
showed  a  rapid  proliferation,  compared  with  cells  in  adherence  (Figure  7B).  For  the  same 
tissue-derived cells in different generations, we found that the proliferation rate slowed down with the 
increase of cell generations (Figure 7C). 
Figure 7. Proliferation features of meningioma cells. (A) Proliferation features of different 
subtypes of tissue-derived cells, Glioma and fetal NSCs (neural stem cells) as control; 
(B)  proliferation  features  of  the  same  subtypes  of  tissue-derived  cells  in  different 
generations; (C) proliferation features of the same subtypes of tissue-derived cells under 
different culture status. 
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Figure 7. Cont. 
 
To evaluate the proliferative capacity of CD133
+ and CD133
− cells, we replated 1 CD133
+ and 
CD133
− cell per well, respectively. After replating, only a small proportion (1–6%) of CD133
+ tumor 
cells  formed  spheres  within  48  days,  whereas  no  in  vitro  sphere  formation  was  observed  with   
CD133
− cells (data not shown). 
2.5. CD133 Expression Level in Meningioma Cells 
Since cells in spheres expressed stem cell marker CD133, and cell proliferation features showed 
obvious differences among different subtypes of tissue-derived cells, the same tissue-derived cells in 
different culture status, and the same tissue-derived cells in different generations, we compared the 
expression of stem cell-like gene CD133 in the different meningioma cells mentioned above. The 
mRNA level of CD133 was assessed by quantitative RT-PCR analysis. The results showed that, for the 
cells from different tissues, CD133 expression in epithelial types was higher than that in fiber types 
(p < 0.05, Figure 8), but no obvious difference from hemangiopericytoma types. For the cells from the 
same meningioma tissue, CD133 expression in meningioma cells under sphere status was significantly 
higher than that under adherent status (p < 0.05 or p < 0.01, Figure 9). For the same tissue-derived 
cells in different generations, we found that the CD133 mRNA level decreased with the increase of 
cell generation, CD133 expression in the earlier generations was obviously higher than that of later 
generations (p < 0.05 or p < 0.01, Figure 10). 
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Figure 8. CD133 expression in meningioma cells from different subtypes of tissue. 1 and 2 
(red): cells from fiber meningioma tissues; 3 and 4 (blue): cells from epithelial meningioma 
tissues; 5 and 6 (green): cells from hemangiopericytoma meningioma tissues. * p < 0.05. 
 
Figure  9.  CD133  expression  in  the  same  subtypes  of  tissue-derived  meningioma  cells 
under  different  culture  status.  Blue:  suspended  sphere  culture;  green:  adherent  culture.   
* p < 0.05; ** p < 0.01; *** p < 0.001. 
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Figure 10. CD133 expression in different generations of the same subtypes of tissue-derived 
meningioma cells. * p < 0.05; *** p < 0.001. 
 
3. Discussion 
Meningiomas  have the  second highest  incidence in  original intracranial  tumors  [17]. However, 
owing to the lack of appropriate model systems, investigations of their biology have been come to a 
halt. Since most meningiomas are benign, primary meningioma cells in culture are often  found at 
senescence,  resulting  in  the  fact  that  studies  on  meningiomas  had  to  depend  on  primary  or  early 
passage cells, except for those cell lines from aggressive variants of Meningiomas or immortalized cell 
lines.  Our  study  showed  that  meningioma  cells  under  defined  conditions  could  be  passaged  over 
fifteen generations. Several factors below may contribute to the successful culture. 
First, the comprehensive method of digestion used in this study contributed to obtaining living cells. 
To establish meningioma cell culture model systems, we developed a comprehensive digestion method, 
which consisted of  three enzyme cocktail recipes  and  a  four-step digestion method. By using the 
comprehensive method of digestion, we obtained a large number of living cells from each subtype of 
meningioma. These living cells would be easier to grow and propagate.   
Second,  meningioma  cells  under  suspended  spheres  status  might  favor  cell  proliferation.  Since 
meningioma cells in monolayer culture were react easily to contact inhibition and enter the quiescent 
and senescence states [2–5], we cultured meningioma cells under suspended spheres, thus avoiding 
contact  inhibition,  and  so  found  that  meningioma  cells  were  not  easy  to  enter  the  quiescent  and 
senescence state. Our study showed that meningioma cells under suspended spheres could be passaged 
over ten generations. On the contrary, meningioma cells in adherent monolayer cultures were only 
passaged for four to six generations.   
Third, there may be stem-like cells in meningiomas. The culture medium and environment in our 
study were appropriate for the growth and proliferation of stem cells. The culture medium in our study 
was conditional NSCs medium containing progesterone and androstenedione, and the culture system 
was a hypoxia system. The NSCs medium in our study is suitable for stem cells culture. Our results 
suggested that there would be stem-like cells in meningiomas, which is consistent with recent the 
identiﬁcation of tumor stem-like cells as tumor- initiating cells in meningiomas [10]. In addition, a lot 
of studies have proved that hypoxia could enhance the generation of embryonic stem cells and induce 
pluripotent  stem  cells  [11]. Therefore, we used NSCs  medium  as  the  basic medium  for culturing 
meningioma cells in a hypoxic environment. In addition, so far, it is not clear what kind of growth Int. J. Mol. Sci. 2012, 13  6435 
 
 
factors can promote the proliferation of meningioma cells. However, defined medium conditioned by 
meningioma cells per se might contain some factors, perhaps identical to a normal endogenous growth 
factor in vivo, capable of stimulating the proliferation of meningioma cells [14]. And the progesterone 
and  androgen  receptor-positive  rate  in  meningioma  tissues  were  relatively  high  [12,13],  so 
progesterone  and  androstenedione  in  the  culture  medium  might  contribute  to  the  growth  and 
proliferation of meningioma cells. 
Since  our  results  indicate  that  there  may  be  stem-like  cells  in  suspended  sphere,  we  further 
investigated the expression level of CD133 of cells from different subtype tissues, different culture 
status, and different generations. For the same subtype of cells in different generations, the expression 
of CD133 of the earlier generation was obviously higher than that of the later generation. During the 
passage culture, we found a decreasing tendency of cell proliferation with increasing cell generation, 
suggesting  that  this  decreasing  tendency  may  be  related  with  a  decline  of  CD133  expression. 
Interestingly, cells from two epithelial subtypes could be passaged up to 15 generations, however, cells 
from  fiber subtypes  were only passaged up to  10 generations.  Accordingly, CD133 expression in 
epithelial subtypes was higher than that in fiber subtypes, further suggesting there was a correlation 
between CD133 expression and cell proliferation rate. For the same subtype of cells under different 
status, we found that cells under suspension could be passaged for more generations, compared with 
those in adherent culture. Accordingly, the expression level of CD133 in cells under suspended spheres 
was  significantly  higher  than  that  under  adherence.  Finally,  single  CD133
+  cells  rather  than   
CD133
− cells could form spheres. All of this indicated that CD133-positive cells might be responsible 
for efficient proliferation of human meningioma cells 
During  the  passage  culture,  we  found  that  some  meningioma  cells  could  form  a  vascular  net. 
Immunocytochemistry detection demonstrated that there was VEGF expression in some of the cells. 
Relationships between stem cells and vascular cells suggested that these VEGF-positive cells might 
derive from CD133-positive cell transdifferentation [18,19]. 
In this study, we also transplanted meningioma cells into animal models to recapitulate the original 
tumor. However, we did not observe the tumor (data not shown). We speculated that stem cells in 
meningioma  tissues  might  only  have  the  characteristics  of  tissue  stem  cell-like  cells.  Therefore, 
meningioma cells in our study only passaged for limited generations, similar to adult neural stem cells. 
In conclusion, our study demonstrated that meningioma cells could be amplicated and passaged 
under  sphere  status  and  conditional  system  without  gene  intervention,  but  the  proliferative  rate 
declined with cell generation and decreasing CD133 expression. In our latest study, we obtained a 
number of clinical specimens (including three fiber meningiomas, two epithelial meningiomas, two 
hemangiopericytom meningiomas). The growth characteristics and trends of meningioma cells from 
these specimens were similar to the corresponding subtypes of this study. Therefore, CD133-positve 
cells might be responsible for the proliferation, and decrease of CD133 level might be one of main 
causes for the decline of proliferative rate. 
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4. Experimental Section 
4.1. Ethics 
The  informed  consents  from  all  participants  involved  in  this  study  were  obtained  verbally.   
All procedures were approved by Human Research Subjects of Huashan Hospital, Fudan University, 
Shanghai, China. 
4.2. Isolation of Meningioma Cells from Meningioma Tissues 
Tumor samples from six human meningioma patients were removed by craniotomy, stored in a 
medium in a sterile test tube and transported to the lab at 4 °C . Tumor tissues were washed ten times 
with pre-cooled PBS, and cut into pieces. Tissue pieces were put into a 15 mL tube, washed in PBS 
and  centrifuged  for  5  min  at  500  ×  g.  Aspirate  supernatant  was  digested  in  PBS-buffered 
collagenase/dispase cocktail, which consisted of 1 mg/mL collagenase, 2 mg/mL dispase, 70 U/mL 
DNase, 0.1% BSA. Digestion was performed for 4 ×  20 min in a 37 ° C rotator oven (four-step method). 
After the  first  20 min, samples  were  gently triturated several  times with 5 mL  stripette (Corning 
Incerperated), and settled for 5 min. The digested top tissue mixture was transferred into a new tube to 
centrifuge and collect cells. Some fresh collagenase/dispase cocktail was added into the remaining 
tissue pieces and digest was continued for the second, third and forth 20 min. During each 20 min, the 
manipulation described for the first 20 min was repeated. 
4.3. Primary Tumor Spheres Culture 
Cells were seeded at a concentration of 5 ×  10
5/mL into substrate-free tissue culture flasks and 
culture  in  a  3%  O2,  5%  CO2  atmosphere.  The  growth  medium  consisted  of  DMEM/F12  (phenol 
red-free) containing 50 units/mL penicillin–streptomycin, B27 (1:50), human recombinant FGF-2 and 
EGF (both at 20 ng/mL), 20 nM progesterone, 100 mM androstenedione and heparin (5 μg/mL). 
4.4. Passaging Sphere Culture 
Passaging was carried out using TrypleTM Express (Invitrogen, Carlsbad, CA, USA) and 70 U/mL 
DNase.  When  the  majority  of  spheres  were  loose,  5  mL  PBS  were  added  and  gently  triturated, 
centrifuged and the cells collect at 300 g for 5 min. Cells were seeded in conditioned medium, which 
consisted of 1/2 of old medium and 1/2 of fresh medium. During passaging culture, 1/2 of the medium 
was changed every 3 days to keep it conditioned at all times. 
4.5. Adherent Culture of Meningioma Cells 
Spheres were triturated into single cell suspension, plated in T-25 flasks with a volume of 5 mL of 
conditional  medium  with  10%  FBS.  The  growth  medium  consisted  of  DMEM/F12  containing 
50 units/mL penicillin–streptomycin, B27 (1:50, Gibco, Grand Island, NY, USA), human recombinant 
FGF-2  and  EGF  (both  at  20  ng/mL),  20  nM  progesterone,  100  mM  androstenedione,  heparin   
(5 μg/mL), and 10% fetal bovine serum (FBS). The cells were passaged according to split ratios: 1:3 or 1:2. Int. J. Mol. Sci. 2012, 13  6437 
 
 
4.6. Cell Proliferation Assays 
Cells  were  plated  in  96-well  plates  in  100  μL  volumes  of  growth  medium,  at  a  density  of   
1000 cells/well. Cell proliferation assays were performed on days 0, 3, 5, and 7 post plating using the 
Cell Proliferation Kit I (MTT). Cells were incubated with MTT solution for approximately 4 h. The 
dye was quantified at 575 nm with an ELISA plate reader. 
4.7. FACS Analysis 
Tumor spheres were digested into single cells. The cell suspension was centrifuged at 300 g for 
5 min.  The supernatant  was  aspirated  completely  and  the cells  were pre-incubated  with  20 μL of 
Affinity Purified Human FcγR-binding inhibitor per 100 μL Flow Cytometry Staining buffer (FCS 
buffer)  for  20  min  on  ice  prior  to  staining.  Ten  microliters  of  PE-labeled  Anti-CD133  antibody 
(Miltenyi  Biotec,  Inc.)  was  added,  mixed  well  and  incubated  for  30  min  in  the  dark  in  a  4  °C  
refrigerator. Cells were washed by adding 2 mL of FCS buffer and centrifuged at 300 g, 4 °C  for   
5 min. This was repeated for a total of two washes, discarding supernatant between washes.  The 
stained cells were resuspended in FCS buffer. Data was acquired on a FACSCalibur machine (BD 
Biosciences).  After  sorting,  1  CD133
+  and  CD133
−  were  replated  into  each  well  to  evaluate  the 
proliferative capacity of CD133
+ and CD133
− cells. 
4.8. Immunocytochemistry 
Tumor  sphere  were  partially  digested  into  cells  and  loose  spheres.  Then  these  cells  and  loose 
spheres  were  replated  on  gelatin-coated  glasses  and  cultured  for  24  h.  Fixed  cells  with  4% 
paraformaldehyde for 5 min at room temperature. After washing three times with PBS, the cells were 
treated with 0.25% Triton X-100, 10% normal donkey serum (Jackson), and 1% bovine serum albumin 
(BSA, Sigma) for 10 min at room temperature. Primary antibodies included CD133 (ab19898, abcam), 
vimentin  (v6630,  sigma),  EMA  (Dako,  Carpinteria,  CA,  USA),  Desmoplakin  (ab109445,  abcam), 
Nestin (Chemicon), bIII-tubulin (CB412, Chemicon), glial fibrillary acidic protein (Z0334, Dako). 
Secondary  antibodies  used  were  Alexa488-conjugated  donkey  anti-rabbit  IgG  (Invitrogen), 
Alexa555-conjugated donkey anti-mouse IgG (Invitrogen). The counterstain of nucleuses was 1 mg/mL 
Hoechst 33342 (Invitrogen). 
4.9. qRT-PCR Analysis 
The methods have been described previously [15]. Total RNA was prepared from cells using the 
Absolutely RNA Nanoprep Kit (Stratagene,). The forward and reverse primers of CD133 were 5′-TCT 
CTA  TGT  GGT  ACA  GCC  G-3′,  5′-TGA  TCC  GGG  TTC  TTA  CCT-3′.  Complementary  DNA 
synthesis and quantitative analysis were performed with AffiniScriptTM Muti Temperature cDNA 
Synthesis  Kit  and  Brilliant  II  Fast  SYBR  Green  QPCR  Master  Mix  (Stratagene)  following  the 
manufacturer’s instructions. Amplification was performed using the ABI 7500 Real Time System. 
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4.10. Western Blot Analyses 
Tumor spheres of each sample were collected for extracting protein. Western blot was performed 
with conventional methods [16]. Protein samples were separated with 15% SDS-polyacrylamide gel 
and transferred onto PVDF membranes (Millipore). The primary antibodies used in this study include 
CD133,  EMA,  vimentin,  VEGF.  Blots  were  washed  and  incubated  for  1  h  with  IRDyeTM800 
conjugated anti-goat and anti-mouse second antibodies. 
4.11. Statistical Analysis 
Data  were  analyzed  using  GraphPad-Prism  software  (version  5.0;  Graphpad  software  Inc.:   
San Diego, CA, USA) and Windows XP Excel 2007 (version 2007; Microsoft: Redmond, WA, USA, 
2007). Statistical analysis was performed using Student’s t test for mRNA level analysis. Probabilities 
(p value) < 0.05 were regarded statistically significant. 
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